InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| AddaVax™ | Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Viru... | 2022 | Vaccines (Basel). | Resch M.D. et al. | DOI: 10.3390/vaccines10121997 |
| Human ACE2 expressing A549 Cells | Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Viru... | 2022 | Vaccines (Basel). | Resch M.D. et al. | DOI: 10.3390/vaccines10121997 |
| G418 (Geneticin) | The Gal4-Type Transcription Factor Pro1 Integrates Inputs from Two Different ... | 2022 | J Fungi (Basel). | Palos-Fernández R. et al. | DOI: 10.3390/jof8121242 |
| Primocin® | SCON-a Short Conditional intrON for conditional knockout with one-step zygote... | 2022 | Exp Mol Med. | Wu S.S. et al. | DOI: 10.1038/s12276-022-00891-0 |
| FLA-ST (Standard or Ultrapure) | Lysosomal cathepsins act in concert with Gasdermin-D during NAIP/NLRC4-depend... | 2022 | Cell Death Dis. | Branco L.M. et al. | DOI: 10.1038/s41419-022-05476-3 |
| Primocin® | Drug response profiles in patient-derived cancer cells across histological su... | 2022 | Br J Cancer | Murumägi A. et al. | DOI: 10.1038/s41416-022-02067-z |
| Anti-CD20 (Rituximab biosimilar - IgG1 isotype) | AL008 Enhances Myeloid Antitumor Function by Inhibiting SIRPα Signaling and A... | 2022 | J Immunol. | Yang J. et al. | DOI: 10.4049/jimmunol.2200157 |
| Zeocin® | Impact of latency-reversing agents on human macrophage physiology. | 2022 | Immun Inflamm Dis. | Hany L. et al. | DOI: 10.1002/iid3.590 |
| TNF-α Reporter HEK 293 Cells | Impact of latency-reversing agents on human macrophage physiology. | 2022 | Immun Inflamm Dis. | Hany L. et al. | DOI: 10.1002/iid3.590 |
| QUANTI-Blue™ | Impact of latency-reversing agents on human macrophage physiology. | 2022 | Immun Inflamm Dis. | Hany L. et al. | DOI: 10.1002/iid3.590 |
| Puromycin | Impact of latency-reversing agents on human macrophage physiology. | 2022 | Immun Inflamm Dis. | Hany L. et al. | DOI: 10.1002/iid3.590 |
| Primocin® | Neuromedin U secreted by colorectal cancer cells promotes a tumour-supporting... | 2022 | Cell Commun Signal | Przygodzka P. et al. | DOI: 10.1186/s12964-022-01003-1 |
| PlasmoTest™ - Mycoplasma Detection Kit | Neuromedin U secreted by colorectal cancer cells promotes a tumour-supporting... | 2022 | Cell Commun Signal | Przygodzka P. et al. | DOI: 10.1186/s12964-022-01003-1 |
| PMA - Phorbol myristate acetate | Neuromedin U secreted by colorectal cancer cells promotes a tumour-supporting... | 2022 | Cell Commun Signal | Przygodzka P. et al. | DOI: 10.1186/s12964-022-01003-1 |
| Blasticidin | Mitochondrial cristae architecture protects against mtDNA release and inflamm... | 2022 | Cell Rep. | He B. et al. | DOI: 10.1016/j.celrep.2022.111774 |
| Poly(I:C) HMW | Mitochondrial cristae architecture protects against mtDNA release and inflamm... | 2022 | Cell Rep. | He B. et al. | DOI: 10.1016/j.celrep.2022.111774 |
| Puromycin | Mitochondrial cristae architecture protects against mtDNA release and inflamm... | 2022 | Cell Rep. | He B. et al. | DOI: 10.1016/j.celrep.2022.111774 |
| R848 (Resiquimod) | miR-31-5p Regulates Type I Interferon by Targeting SLC15A4 in Plasmacytoid De... | 2022 | J Inflamm Res. | Li S. et al. | DOI: 10.2147/JIR.S383623 |
| Alhydrogel® adjuvant 2% | Vaccination with a Zika virus envelope domain III protein induces neutralizin... | 2022 | Trop Med Health | Shin M. et al. | DOI: 10.1186/s41182-022-00485-6 |
| G418 (Geneticin) | Cohesin and CTCF control the dynamics of chromosome folding. | 2022 | Nat Genet. | Mach P. et al. | DOI: 10.1038/s41588-022-01232-7 |